Lymphatic Pump Treatment as an Adjunct to Antibiotics for Pneumonia in a Rat Model

Abstract Background: Lymphatic pump treatment (LPT) is a technique used by osteopathic physicians as an adjunct to antibiotics for patients with respiratory tract infections, and previous studies have demonstrated that LPT reduces bacterial load in the lungs of rats with pneumonia. Currently, it is unknown whether LPT affects drug effcacy. Objective: To determine whether the combination of antibiotics and LPT would reduce bacterial load in the lungs of rats with acute pneumonia. Methods: Rats were infected intranasally with 5×107 colony-forming units (CFU) of Streptococcus pneumoniae. At 24, 48, and 72 hours after infection, the rats received no therapy (control), 4 minutes of sham therapy, or 4 minutes of LPT, followed by subcutaneous injection of 40 mg/kg of levofoxacin or sterile phosphate-buffered saline. At 48, 72, and 96 hours after infection, the spleens and lungs were collected, and S pneumoniae CFU were enumerated. Blood was analyzed for a complete blood cell count and leukocyte differential count. Results: At 48 and 72 hours after infection, no statistically significant differences in pulmonary CFU were found between control, sham therapy, or LPT when phosphate-buffered saline was administered; however, the reduction in CFU was statistically significant in all rats given levofoxacin. The combination of sham therapy and levofoxacin decreased bacterial load at 72 and 96 hours after infection, and LPT and levofoxacin significantly reduced CFU compared with sham therapy and levofoxacin at both time points (P<.05). Colony-forming units were not detected in the spleens at any time. No statistically significant differences in hematologic findings between any treatment groups were found at any time point measured. Conclusion: The results suggest that 3 applications of LPT induces an additional protective mechanism when combined with levofoxacin and support its use as an adjunctive therapy for the management of pneumonia; however, the mechanism responsible for this protection is unclear.

[1]  H. King,et al.  Lymphatic pump treatment repeatedly enhances the lymphatic and immune systems. , 2013, Lymphatic research and biology.

[2]  C. Creasy,et al.  Thoracic and abdominal lymphatic pump techniques inhibit the growth of S. pneumoniae bacteria in the lungs of rats. , 2013, Lymphatic research and biology.

[3]  B. Vargaftig,et al.  Intestinal lymph-borne factors induce lung release of inflammatory mediators and expression of adhesion molecules after an intestinal ischemic insult. , 2012, The Journal of surgical research.

[4]  Lisa Hodge.  Osteopathic lymphatic pump techniques to enhance immunity and treat pneumonia. , 2012, International journal of osteopathic medicine : IJOM.

[5]  H. Downey,et al.  Lymphatic pump treatment enhances the lymphatic and immune systems , 2011, Experimental biology and medicine.

[6]  M. Niederman,et al.  Management of community-acquired pneumonia: a review and update , 2011, Therapeutic advances in respiratory disease.

[7]  H. Downey,et al.  Lymphatic pump treatment augments lymphatic flux of lymphocytes in rats. , 2010, Lymphatic research and biology.

[8]  M. J. Hall,et al.  National Hospital Discharge Survey: 2007 summary. , 2010, National health statistics reports.

[9]  H. King,et al.  Lymphatic pump treatment mobilizes leukocytes from the gut associated lymphoid tissue into lymph. , 2010, Lymphatic research and biology.

[10]  H. Downey,et al.  Lymphatic pump manipulation mobilizes inflammatory mediators into lymphatic circulation , 2010, Experimental biology and medicine.

[11]  C. Frei,et al.  Health economics of use fluoroquinolones to treat patients with community-acquired pneumonia. , 2010, The American journal of medicine.

[12]  Jane C. Johnson,et al.  Efficacy of osteopathic manipulation as an adjunctive treatment for hospitalized patients with pneumonia: a randomized controlled trial , 2010, Osteopathic medicine and primary care.

[13]  N. Dean,et al.  Fluoroquinolones in the management of community‐acquired pneumonia , 2010, International journal of clinical practice.

[14]  Po-Huang Lee,et al.  Propofol Attenuates the Decrease of Dynamic Compliance and Water Content in the Lung by Decreasing Oxidative Radicals Released from the Reperfused Liver , 2008, Anesthesia and analgesia.

[15]  Y. Hsu,et al.  Propofol exerts protective effects on the acute lung injury induced by endotoxin in rats. , 2007, Pulmonary pharmacology & therapeutics.

[16]  H. King,et al.  Abdominal lymphatic pump treatment increases leukocyte count and flux in thoracic duct lymph. , 2007, Lymphatic research and biology.

[17]  J. Tune,et al.  Increased Lymphatic Flow in the Thoracic Duct During Manipulative Intervention , 2005, The Journal of the American Osteopathic Association.

[18]  E. Deitch,et al.  A study of the biologic activity of trauma-hemorrhagic shock mesenteric lymph over time and the relative role of cytokines. , 2004, Surgery.

[19]  E. Deitch,et al.  Factors in intestinal lymph after shock increase neutrophil adhesion molecule expression and pulmonary leukosequestration. , 2003, The Journal of trauma.

[20]  E. Deitch,et al.  Mesenteric lymph from rats subjected to trauma-hemorrhagic shock are injurious to rat pulmonary microvascular endothelial cells as well as human umbilical vein endothelial cells. , 2001, Shock.

[21]  Donald R. Noll,et al.  Benefits of osteopathic manipulative treatment for hospitalized elderly patients with pneumonia , 2000, The Journal of the American Osteopathic Association.

[22]  B. J. Winterson,et al.  The effects of manually applied intermittent pulsation pressure to rat ventral thorax on lymph transport. , 2000, Lymphology.

[23]  A. Roberts,et al.  Effect of lymphatic and splenic pump techniques on the antibody response to hepatitis B vaccine: a pilot study. , 1998, The Journal of the American Osteopathic Association.

[24]  B. Degenhardt,et al.  Update on osteopathic medical concepts and the lymphatic system , 1996, The Journal of the American Osteopathic Association.

[25]  J. Measel.  The effect of the lymphatic pump on the immune response: I. Preliminary studies on the antibody response to pneumococcal polysaccharide assayed by bacterial agglutination and passive hemagglutination , 1982, The Journal of the American Osteopathic Association.

[26]  Measel Jw.  The effect of the lymphatic pump on the immune response: I. Preliminary studies on the antibody response to pneumococcal polysaccharide assayed by bacterial agglutination and passive hemagglutination. , 1982 .

[27]  G. Lamberti,et al.  Institutional Animal Care and Use Committee , 2017 .

[28]  T. W. Allen,et al.  The use of the thoracic pump in treatment of lower respiratory tract disease. , 1967, The Journal of the American Osteopathic Association.